Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

S Science Co Ltd (5721)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
23.0 -1.0    -4.35%
26/04 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 102,900
  • Bid/Ask: 22.0 / 23.0
  • Day's Range: 22.0 - 23.0
Type:  Equity
Market:  Japan
ISIN:  JP3359200007 
S Science Co Ltd 23.0 -1.0 -4.35%

5721 Balance Sheet

 
Assess the latest S Science Co Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 5721 Annual Report data, financial summaries and charts are available for S Science Co Ltd investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 3243 3242 - 2341
Cash and Short Term Investments 2321 2121 - 1310
Cash - - - -
Cash & Equivalents 1903 1304 - 1303
Short Term Investments 418 817 - 7
Total Receivables, Net 214 312 - 226
Accounts Receivables - Trade, Net 214 312 - 226
Total Inventory 679 777 - 714
Prepaid Expenses - - - -
Other Current Assets, Total 29 32 - 91
Total Assets 3383 3382 - 2947
Property/Plant/Equipment, Total - Net 1 1 - 2
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments 138 138 - 601
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 1 - 1
Other Assets, Total 912 1314 - 588
Total Current Liabilities 183 330 - 207
Accounts Payable 133 178 - 131
Payable/Accrued - - - -
Accrued Expenses - 2 - 2
Notes Payable/Short Term Debt 3 3 - 3
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 47 147 - 71
Total Liabilities 273 419 - 317
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - 24
Minority Interest - - - -
Other Liabilities, Total 87 83 82 80
Total Equity 3110 2963 - 2630
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 100 100 - 100
Additional Paid-In Capital 2597 2597 - 2597
Retained Earnings (Accumulated Deficit) 413 266 - -113
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - 46
Total Liabilities & Shareholders' Equity 3383 3382 - 2947
Total Common Shares Outstanding 141.59 141.59 141.59 141.59
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

5721 Price Commentary

Write your thoughts about S Science Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email